VS
stockvs
Go to ScreenerHub
ABBV

ABBV vs MRK

MRK

In the past 12 months, MRK returned +22% while ABBV gained 3%.

ABBV
ABBV

AbbVie Inc.

$221.45
-4.9%(1M)
Market Cap391.6B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio95.64
ROE-3.6%
P/B Ratio-123.60
Dividend Yield2.9%
MRK
MRK

Merck & Co., Inc.

$115.42
-5.1%(1M)
Market Cap285.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio15.97
ROE36.2%
P/B Ratio5.54
Dividend Yield2.8%
Performance Comparison

Historical returns across multiple timeframes

ABBV

ABBV

AbbVie Inc.

+3.3%

1Y Return

MRK

MRK

Merck & Co., Inc.

+21.8%

1Y Return

ABBV
ABBV
MRK
MRK

Short Term

1M-6M

MRK
+18.2%

Medium Term

YTD-1Y

MRK
+15.1%

Long Term

3Y-10Y

ABBV
+145.2%

Valuation

Compare price multiples and valuation ratios

ABBV: 2MRK: 3
MetricABBVMRKWinner
P/E Ratio

Price to earnings ratio

95.6415.97MRK
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.564.45MRK
P/B Ratio

Price to book ratio

-123.605.54ABBV
P/FCF Ratio

Price to free cash flow ratio

21.4623.42ABBV
EV/EBITDA

Enterprise value to EBITDA

16.4112.34MRK
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

ABBV: 0MRK: 6
MetricABBVMRKWinner
Gross Margin

Gross profit margin

73.3%81.5%MRK
Operating Margin

Operating profit margin

26.7%41.2%MRK
Net Margin

Net profit margin

6.9%28.1%MRK
ROE

Return on equity

-3.6%36.2%MRK
ROA

Return on assets

3.2%13.3%MRK
ROIC

Return on invested capital

10.6%20.8%MRK

Growth

Compare revenue and earnings growth rates

ABBV: 1MRK: 5
MetricABBVMRKWinner
Revenue Growth (YoY)

Year-over-year revenue growth

8.6%1.3%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

1.8%3.1%MRK
Revenue Growth (5Y)

5-year revenue CAGR

6.0%9.4%MRK
EPS Growth (YoY)

Year-over-year EPS growth

-1.3%8.0%MRK
EPS Growth (3Y)

3-year EPS CAGR

-29.1%8.4%MRK
EPS Growth (5Y)

5-year EPS CAGR

-2.8%21.2%MRK

Balance Sheet & Risk

Compare financial stability and debt levels

ABBV: 1MRK: 4
MetricABBVMRKWinner
Debt/Equity

Debt to equity ratio

-21.060.96ABBV
Current Ratio

Current assets to current liabilities

0.671.54MRK
Quick Ratio

Quick assets to current liabilities

0.561.30MRK
Interest Coverage

EBIT to interest expense

5.7728.34MRK
Beta

Stock volatility vs market

0.330.26MRK
Summary
MRK wins 4-0

Valuation

MRK

Profitability

MRK

Growth

MRK

Balance Sheet

MRK

MRK is more attractively valued. MRK shows stronger profitability. MRK demonstrates better growth. MRK has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into ABBV and MRK with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/ABBV/vs/MRK" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare ABBV vs MRK on stockvs.app
</a>